Furthermore, in non-small-cell lung cancer (NSCLC) anti-Cer antibodies were supposed to be produced by the tumor and its microenvironment, and to neutralize pro-apoptotic effect of Cer. This evidence concerns the gene CBLN1 and non-small cell lung carcinoma.